LivaNova (LIVN) Share-based Compensation (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.91% |
| Dec 31, 2025 | -5.62% |
| Sep 30, 2025 | 8.43% |
| Jun 30, 2025 | 17.87% |
| Mar 31, 2025 | 12.00% |
| Dec 31, 2024 | -18.81% |
| Sep 30, 2024 | 4.39% |
| Jun 30, 2024 | -19.82% |
| Mar 31, 2024 | 23.46% |
| Dec 31, 2023 | -29.68% |
| Sep 30, 2023 | 106.25% |
| Jun 30, 2023 | -46.02% |
| Mar 31, 2023 | -14.11% |
| Dec 31, 2022 | 14.82% |
| Sep 30, 2022 | -6.79% |
| Jun 30, 2022 | 12.22% |
| Mar 31, 2022 | 2.66% |
| Dec 31, 2021 | -10.18% |
| Sep 30, 2021 | 12.16% |
| Jun 30, 2021 | 3.98% |
| Mar 31, 2021 | 15.67% |
| Dec 31, 2020 | 5.54% |
| Sep 30, 2020 | -21.82% |
| Jun 30, 2020 | 10.48% |
| Mar 31, 2020 | 7.32% |
| Dec 31, 2019 | -1.23% |
| Sep 30, 2019 | -2.21% |
| Jun 30, 2019 | 26.95% |
| Mar 31, 2019 | 24.13% |
| Dec 31, 2018 | -22.76% |
| Sep 30, 2018 | -4.95% |
| Jun 30, 2018 | 12.87% |
| Mar 31, 2018 | 38.88% |
| Dec 31, 2017 | -15.44% |
| Sep 30, 2017 | 20.51% |
| Jun 30, 2017 | 22.79% |
| Mar 31, 2017 | -3.76% |
| Dec 31, 2016 | -16.23% |
| Oct 18, 2015 | 279.95% |
| Jul 24, 2015 | 124.67% |